Fig. 1: The prognostic significance of gain/amp(1q) at different clonal sizes in NDMM. | Leukemia

Fig. 1: The prognostic significance of gain/amp(1q) at different clonal sizes in NDMM.

From: Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma

Fig. 1: The prognostic significance of gain/amp(1q) at different clonal sizes in NDMM.

Kaplan-Meier analysis of PFS (A) and OS (D) by gain/amp(1q). Kaplan-Meier analysis of PFS (B) and OS (E) by clonal size. NDMM patients with gain/amp(1q) are grouped using cutoff values of 20% and 50%. Kaplan–Meier analysis of PFS (C) and OS (F) by clonal size. NDMM patients with gain/amp(1q) are grouped using a cutoff value of 20%. NS not significant, *P < 0.05, ***P < 0.001, by two-sided log-rank test.

Back to article page